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Abstract
The Healthcare sector has been at the forefront of the adoption of artificial intelligence (AI) technologies. Owing to the nature of
the services and the vulnerability of a large section of end-users, the topic of responsible AI has become the subject of widespread
study and discussion.We conduct a mixed-method study to identify the constituents of responsible AI in the healthcare sector and
investigate its role in value formation and market performance. The study context is India, where AI technologies are in the
developing phase. The results from 12 in-depth interviews enrich the more nuanced understanding of how different facets of
responsible AI guide healthcare firms in evidence-based medicine and improved patient centered care. PLS-SEM analysis of 290
survey responses validates the theoretical framework and establishes responsible AI as a third-order factor. The 174 dyadic data
findings also confirm the mediation mechanism of the patient’s cognitive engagement with responsible AI-solutions and per-
ceived value, which leads to market performance.
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1 Introduction
In recent years, there has been an enhanced focus on artificial
intelligence (AI) in various domains, to resolve complex is-
sues (Chen, 2018; Duan et al., 2019; Dwivedi et al., 2020;
2021; Reddy, 2018). In healthcare, various forms of AI tech-
nologies have enabled the service providers to automate the
process and personalize the service delivery (Ahmed et al.,
2018; Brisimi et al., 2018; Shareef et al., 2021). AI has en-
abled the delivery of precisionmedicine and holds the promise
of liberating patient data (Wang et al., 2018). However, these
rapid advancements of AI technologies create numerous
challenges and raise legitimate concerns (Sivarajah et al.,
2017; Vayena et al., 2018). In effect, a responsible approach
to AI has received significant attention from scholars and
practitioners, to ensure fair use and sustainable impact of AI
technologies (Bag et al., 2021; Balakrishnan & Dwivedi,
2021; Dubey et al., 2020; Gursoy et al., 2019; Ismagilova
et al., 2020; Nishant et al., 2020; Pillai et al., 2020; 2021;
Wang et al., 2020; Wearn et al., 2019). Responsible AI is
characterized by ethical and accountable solutions in organi-
zational strategies and design (He et al., 2019).
Utilization of recent AI technologies in healthcare, coupled
with patient’s growing adoption of AI-enabled devices, allows
collection and storage of and access to large scale data, both
by healthcare providers and technology vendors (Fox &
James, 2020; Mikalef & Gupta, 2021; Shareef et al., 2021).
Despite the many potential benefits of such rapid technologi-
cal advances in AI, its dark side calls for a responsive design
and implementation as riskmitigationmeasures (Ahmed et al.,
2018; Khalifa et al., 2019). Some common risks include se-
curity of healthcare databases and applications, violation of
the end user’s privacy, and the social risks associated with
uneven distribution of benefits (Fox & James, 2020; Wang
et al., 2018). Especially in countries with a significant margin-
al population, AI increases the vulnerability of a large section
of end-users. The recent report on National Strategy for
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Artificial Intelligence in India indicates that advancements in
AI-based technologies present potential solutions to various
challenges in healthcare delivery to the community (AHHM,
2017). Responsible AI is an attempt to mitigate the aforesaid
risks, while simultaneously adapting to the needs of the di-
verse and marginalized sections of society (Ghallab, 2019;
Obermeyer et al., 2019; Winter & Davidson, 2019).
Although there is growing concern regarding the benefits
and implementation of AI technologies, what constitutes re-
sponsible AI is still unclear.
Many studies provide evidence of the use of AI to influence
clinical practices and the overall patient journey (Daugherty
et al., 2019). Digital healthcare in India has improved the
efficiency in processes and enhanced patient care. New health
technologies such as wearable devices, growth of telemedi-
cine, virtual reality, robotics and artificial intelligence (AI) are
changing the landscape of the Indian healthcare sector
(Markets, 2020). A paradigm shift in the healthcare delivery
system is observed through the application of AI to radio-
diagnosis, drug discovery, patient risk identification, and elec-
tronic health monitoring (Doumbouya et al., 2014; Rahman
et al., 2016; Saha & Ray, 2019). Substantial growth in AI
technologies has supported the healthcare service providers
in basic guidance to the patients, problem-solving, and sup-
ports for various medical issues (Daugherty et al., 2019).
Healthcare practitioners emphasize that AI based technologies
are helpful not only in identifying the intensity of treatment,
but also in classifying them into high risk or very high risk
groups (Tyagi, 2019). Researchers further envisage that mar-
ket, liability laws, external regulations, and internal motiva-
tion may force the healthcare industry to adopt responsible AI
sooner than later (Wang et al., 2018). The demonstrable pro-
ductivity of responsible AI improves market performance in
healthcare (Chace, 2015; He et al., 2019). Additionally, the
patients’ adoption of AI-driven solutions is expected to wit-
ness an exponential increase in the next few years (Manyika
et al., 2013).
The National e-Health Authority provides evidence of the
potential market for AI driven applications in India (NeHA,
2016). Several companies like Google,Microsoft and IBM are
creating an AI-focused network and partnership with Indian
hospitals and governments (NITI Aayog, 2016). Healthcare
companies are utilizing recent technologies and AI-based so-
lutions to capture patient’s interest and for steering new busi-
ness strategies (Basu et al., 2021). According to the Future
Health Index (FHI), the applications of AI in the healthcare
sector in India would be worth US$ 6 billion by 2021 (FHI,
2020). As such, India is leading in the adoption of digital
healthcare services and is expected to drive the healthcare
market at a CAGR of 20 % by the end of 2022 (AHHM,
2017). Recent reports predict that by 2025, there would be a
$520 billion opportunity from value creation through socially
responsible AI, in the Indian healthcare market (Burkhardt
et al., 2019; Chatterjee, 2020). Digital health technology is a
pivotal pillar in delivering value-based care across the
healthcare continuum in India. These levers of value creation
have immense potential to increase the health expenditure
aligned with market growth. Thus, the capabilities of respon-
sible AI will drive the healthcare market and enable healthcare
customers (patients) experience a dynamically different ser-
vice environment through evidence-based approaches.
Pre-eminent studies in this field argue that developing re-
sponsible AI is aimed at minimizing the patent’s distrust and
improving their cognitive engagement with AI-enabled tech-
nologies (Ismagilova et al., 2020; Porra et al., 2020). Recent
studies have extensively examined how customer’s perspec-
tives and the factors underlying the adoption of various newer
technologies, are essential for framing marketing strategies
(Khanna et al., 2012; Rana & Dwivedi, 2016). However, al-
though the concept of cognitive engagement with socially
responsible AI technologies promises to deliver significant
value, many gaps still exist regarding the linkages of ‘cogni-
tive engagement’ in the formation of a patient’s perceived
value. Therefore, understanding the patient’s perception of
responsible AI and the value creation process remains a vital
facet of marketing. This research aims to improve such under-
standing of responsible AI, while considering the psycholog-
ical perspective of patients and their linkages with value for-
mation and market performance.
This study is guided by the following research questions:
1. What are the components of responsible AI in
healthcare?
2. What is the impact of responsible AI on patients’ per-
ceived value and market-performance?
3. Does cognitive engagement mediate the relationship be-
tween responsible AI and perceived value?
We conducted a mixed-method sequential approach to ex-
amine the components of responsible AI. The sample was
collected from Indian healthcare systems. The first stage of
the study was exploratory interviews (N = 12) to explain the
relevance of the constructs under study and identify additional
measurement parameters. In the second stage, a quantitative
survey (N = 290) was conducted among healthcare profes-
sionals, which established responsible AI as a third-order fac-
tor. Finally, we collected dyadic data (N = 174) utilizing a
survey of healthcare professionals and patients. We used
PLS-SEM to test the proposed relationships. The findings
highlight the complex factors of responsible AI. This study
is a first step to establish the constituents of responsible AI as a
third-order factor. The results of this study enrich the more
nuanced understanding of how responsible AI influences the
patient’s instrumental and terminal values, which in turn affect
market performance. The findings of the study bridge the gap
between theory and practice by clarifying how ethical con-
cerns, technical skills, and risk mitigation factors should be
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implemented to design responsible AI systems. Our study
confirms the mediating mechanism of cognitive engagement
with responsible AI and instrumental and terminal values. The
implications for researchers and practitioners are discussed,
emphasizing that healthcare service providers need to design
responsible AI to develop value propositions and improve
market performance.
2 Literature Review and Hypothesis
Development
In recent years, AI has achieved an accelerated momentum to
deliver the best possible outcomes and is increasingly preva-
lent in business and society (Sharma et al., 2016). Proponents
of AI point out its affording tremendous potential to affect
every sphere of human life and activity. Although artificial
intelligence technology is inherently complex, integrated,
and spread across multiple organizations, the capabilities of
AI to drive revenues and profitability have opened a wealth of
opportunities across the field (Bichinadaritz &Marling, 2006;
He et al., 2019; Shukla & Sushil, 2020).
2.1 AI for Healthcare
In healthcare, AI has a crucial role in improving the clinical
outcomes and overall efficiency of managerial activities. Prior
studies have outlined how AI can improve healthcare delivery
by augmenting human abilities, supporting mental health, and
precise diagnosis (WHO, 2020b; Wu et al., 2021). The AI
technology allows us to gain information, process it, and gen-
erate a well-defined output for medical professionals (Reddy,
2018; Wang et al., 2018). AI technologies possess data-
mining and pattern recognition capabilities that enable the
prediction, diagnosis and treatment (Kok et al., 2013). Early
attempts to apply AI technologies in medicine were intended
to replicate the functions of the human brain and set up a rule-
based system to assist medical reasoning (He et al., 2019;
Warwick, 2013). Further developments in AI were focused
on replicating the intellectual function of the physician.
However, the modern products of AI technologies are over-
coming the various limitations of clinicians and complexities
in the care process (Reddy, 2018; Wang et al., 2020). The
application of AI converts analytical insights into cognitive
engagement solutions that enhance diagnosis, improve predic-
tive interventions, and optimize clinical productivity (Fox &
James, 2020; Porra et al., 2020; Wang et al., 2018).
AI technology is capable of accelerating the shift from
traditional hospital settings to customer-focused care sites like
ambulatory surgical centers, retail clinics, and home care
(Barello et al., 2016; Manyika et al., 2013). Further, home
care and wearable devices may lower the overall health costs
by 20 to 32% (Saha & Ray, 2019; Sultan, 2015). AI-enabled
technologies have opened up a new vista of home infusion and
observation care models, which are expected to grow by more
than 18 % over the next five years (OECD, 2019).
Specifically, it is becoming easier to understand patient’s
health patterns, with improvements in predictive analytics,
enabling clinicians to remotely monitor patients under home
care or through connected devices. Thus, healthcare profes-
sionals have benefitted from improved prevention, diagnosis,
and care processes.
On the other hand, the inherent power of AI creates sub-
stantial threats to organizations, stakeholders, and the industry
supply chain (Obermeyer et al., 2019; Sivarajah et al., 2017).
Past studies have reported that the more advanced the AI, the
greater are the challenges and threats it poses humanity. Risks
associated with AI include (but are not limited to) the safety of
critical AI applications, security and privacy of user data, and
social risks (Joubert et al., 2021; Porra et al., 2020; Sharma &
Sharma, 2019; Vellido, 2019). For instance, the collection of
patient data by AI algorithms raises serious issues of privacy
invasion, transparency, and information leakage (Fox &
James, 2020). Wang et al. (2020) catalogue several risks for
healthcare deliveries like compromising transparency stan-
dards, neglecting fair clinical deployment, and ignoring the
algorithmic biases. Thus, the utilization of such advanced
technologies has exposed individuals to many risks at various
levels of data collection and processing. Consequently, there
has been an increasing concern about the ethical issues and
legitimacy associated with AI technologies (Deven & Joshua,
2017; Lui & Lamba, 2018). In recent years, tremendous con-
cern about AI has been a expressed in various forums, corpo-
rations, and government departments (NAH, 2020; NeHA,
2016; Thomas, 2020) in India. The Medical Council of India
has implemented data protection regimes to regulate ‘private
data’ (MCI, 2016). Consequently, a shift in focus has been
observed to the development and implementation of AI tech-
nologies that are socially responsible.
2.2 Responsible AI in Healthcare
Wang et al. (2020) define responsible AI as “the integration of
ethical and responsible use of AI into the strategic implemen-
tation and planning process.“ Responsible AI primarily aims
to design ethical, transparent, and accountable solutions (Fox
& James, 2020; Shaikhina & Khovanova, 2017; Winter &
Davidson, 2019). To Abosaq (2019), responsible AI is a tool
helpful for organizations to improve trust and minimize pri-
vacy invasion. Past studies highlight the importance of inves-
tigating ethical considerations, technical skills concerning da-
ta and algorithms, and risk mitigation strategies, in leveraging
AI developments (Shaikhina & Khovanova, 2017; Zink &
Rose, 2020; Zuboff, 2015). Several studies have furthered this
discussion of responsible AI and suggest that different techni-
cal and analytical skills are required to build and use AI
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responsibly (Chatterjee, 2020; Gupta & George, 2016; Hung
et al., 2007). Technical skills should focus on the alignment of
stakeholders’ expectations for the use of data. The magnitude
of risk often dictates the importance of risk mitigation strate-
gies. The term responsible AI encompasses all these risk-
mitigating activities. Such strategies will need wider collabo-
rations (Bengatson & Kock, 2000; Campbell, 2007).
Burkhardt et al. (2019) argue that it is generally the external
regulations and internal motivation that force a typical AI firm
to strive for safer AI products. Such efforts, however, do not
always lead to increased profit or reduced litigation cost.
Hence, it is crucial to identify factors that can facilitate co-
operative development of responsible AI, rather than a com-
petitive battle in the market. Trust among stakeholders and
high shared gains from cooperation are a couple of such fac-
tors (Hung et al., 2007). Several researchers opined that AI-
based systems are intrinsically autonomous, interactive, and
adaptable (Chace, 2015; Hsu et al., 2021; Shaikhina &
Khovanova, 2017). While exploring AI, Wang et al. (2020)
integrate it with the ART principles: accountability, responsi-
bility and transparency. Accountability would ensure that all
the decisions and outcomes are justified to all the stake-
holders. These decisions should be derivable from the original
set of data or information used. Responsibility would ensure
that all the developers and researchers are aware of their com-
mitment, more so in cases where the impact of AI on society is
significant and direct. Finally, transparency would ensure that
the mechanism through which AI makes a particular decision
is described to the stakeholders, who should be able to further
inspect and reproduce the process of decision making. This is
a significant departure from the existing, more popular black-
box approach of AI (Barrat, 2013; Chopra, 2019; Kok et al.,
2013).
Though these concepts of accountability, responsibility,
and transparency may be considered essentials of a
responsible AI, their applicability dictates acceptance
boundaries. For instance, Wang et al. (2018) hold
explainability to be core to responsible AI. However, the ex-
pectations of a typical end-user, especially in the healthcare
domain, might vary. The authors explain this with an example
of a healthcare application that predicts skin cancer with the
help of images. In this context, most patients would care less
about the model’s nuances and more about its accuracy of
prediction and recommendations. Thus, the same principles
need to be applied differently in diverse application areas.
Many studies further point to the importance of appropriate
data acquisition, data-set suitability, fairness of AI outputs,
and regulatory compliance and engagement, in the context
of leading an organization to use responsible AI (Burkhardt
et al., 2019; Duan et al., 2019; Dwivedi et al., 2021; Grover
et al., 2020; Fuentes, 2015; Wearn et al., 2019). Al-quaness
et al. (2020) utilized COVID-related responses to highlight the
gaps and potential pitfalls in the existing AI approach. These
include algorithm bias and discrimination, adverse data im-
pact, lack of process transparency, and model interpretability.
According to the authors, the challenges to autonomy, priva-
cy, and public trust are also evident in various COVID-related
contact tracing applications. In this context, it was also ob-
served that some of these solutions tend to shift focus from
supporting effective medical response to the concerns of mass
surveillance and politics of public distrust. A responsible AI
approach in such a context would emphasize reproducibility,
replicability, and transparency. Numerous studies further pro-
pose key steps for responsible AI, including advice to open
science, share data responsibly, adopt ethical principles, gen-
erate public trust, foster equitable innovation and protect the
interests of the vulnerable (Dwivedi et al., 2021; GDPR, 2019;
Modjarrad et al., 2016).
It is evident from the above discussion that responsible AI
is a multi-dimensional construct focusing on technical chal-
lenges and skills, ethical concerns, and risk mitigation. The
critical appraisal of the existing literature thus reveals the con-
stituent elements of responsible AI. This study conceptualizes
responsible AI as a third-order factor (see Fig. 1).
In healthcare, value creation is recognized as an essential
element of the service provider’s competitive strategy (Da
Silva et al., 2015; Sergio, 2015). Management researchers
have identified that actively managing value and devising
ways to develop value propositions are crucial for sparking
growth (Chen et al., 2017).The means-end theory (Rokeach,
1973) states that personal values include instrumental values
and terminal values, holding that personal values influence
individual behavior. According to Parry (2001), the means-
end theory suggests that personal values are the end that peo-
ple seek, while the means help achieving such end. In the
current study context, the means are patients’ experience of
positive consequences of responsible AI. Based on past stud-
ies (Amit & Zott, 2001; De Sarbo et al., 2001), we posit that
patients perceive different benefits from these technologies
that affect instrumental and terminal values. Responsible AI
makes patient interactions more convenient and trustworthy.
These platforms deliver the financial benefit of cost reduction
and psychological benefits of variety and creating instrumen-
tal value of cheerfulness. Besides, these platforms provide
functional benefits through reduced hospitalization and a
hassle-free care process. Thus, the patients perceive the instru-
mental values of cheerfulness, self-control, and responsibility.
Chen et al. (2017) found that experiential benefits create cus-
tomer terminal value. Easy access and risk reduction by en-
gaging with responsible AI infuses confidence in patients in
sharing personal information. Responsible AI solutions deliv-
er psychological benefits of risk reduction, making patients
feel happy and comfortable. Risk reduction by utilizing AI
technologies creates the terminal value of nostalgia
(Almquist et al., 2016). Magids et al. (2015) explored
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emotional-connection-driven opportunities and found that
these technologies make sense of freedom and belongingness,
thus driving customer behavior and creating terminal value.
Thus, responsible AI provides benefits that are perceived as
offering more terminal value.
Therefore, it is hypothesized that:
H1: Responsible AI in healthcare has a positive influ-
ence on perceived instrumental value.
H2: Responsible AI in healthcare has a positive influ-
ence on perceived terminal value.
2.3 Value Formation and Market Performance
Market performance is defined as the capability to enter new
markets and introduce new services faster than the competitors
(Ravichandran & Lertwongsatien, 2005). Wang et al. (2012)
posit thatmarket performance indicates amore significantmarket
share and success rate than the competitors. Several researchers
and practitioners argue that customer value is an essential ele-
ment of a firm’s market performance. According to Chen et al.
(2017), customer valuemanagement is a strategic tool to enhance
market performance.Many studies indicate a significant relation-
ship between perceived value and market-based outcomes
(Javalgi et al., 2005; Johnson et al., 2003; Ravichandran &
Lertwongsatien, 2005). Lusch and Nambisan (2015.p.159) stress
that “the organization’s performance will fall or rise based on the
perceived value.“Many studies have shown that the customer’s
perceived value is a critical measure of the firm’s market perfor-
mance (Brozovic et al., 2016; Gronroos & Ravald, 2010).
According to Chen et al. (2017), a customer’s perceived value
is a subjective indicator of a firm’s market performance.
Ravichandran and Lertwongsatien (2005) showed that customer
value improves market share and enables firms to remain com-
petitive in the market. Researchers believe that the several value
characteristics (e.g., courage, cheerfulness, responsibility, and
self-control) perceived by the customers indicate the firm’s suc-
cess and thus affect market performance. Similarly, many re-
searchers posit that customer’s perceived terminal values (e.g.,
pleasure, comfort and self-respect) help in the introduction of
new services and affect market performance. Existing studies
aver that perceived value remains a vital issue for healthcare
services (Da Silva et al., 2015; Nair et al., 2013). The overall
market performance of a healthcare firm is a function of per-
ceived values. Patients’ evaluation of a specific service attribute
is likely to affect their relationships with the service provider,
which affects the firm’s market performance. Past studies (Bate
& Robert, 2007) indicate that the beliefs and impressions cus-
tomers hold toward a service provider form a brand image, which
influences the latter’s market performance. Likewise, the per-
ceived instrumental and terminal values of socially responsible
AI technologies being utilized in various care procedures gener-
ate the best performance outcomes.
Thus, we postulate that:
H3: Patients’ perceived instrumental value positively
influences market performance.
H4: Patients’ perceived terminal value positively influ-
ences market performance.
2.4 Cognitive Engagement with Responsible AI
Cognitive engagement is connected to what the patient knows,
understands, and how he/she makes sense of the disease, its
treatments, its possible development, and its monitoring
(Serino et al., 2014). As a significant part of the overall
























learning and experience process, cognitive engagement en-
ables patients to immerse in in-depth learning processes situ-
ated in realistic healthcare problems (Gen, 2015). AI technol-
ogies in healthcare aim to increase patients’ cognitive engage-
ment with those applications and tools providing personalized
care (Reddy, 2018). A recent study (Singhal & Carlton, 2019)
states that AI technologies are designed to help patients’ to
improve their health conditions, make informed decisions, and
engage effectively and efficiently with the healthcare system.
Graffigana et al. (2015) described the dynamic nature of cog-
nitive engagements as a psychosocial phenomenon resulting
from the conjoint beliefs, goals, and epidemiology enactment
of individuals towards their health condition and manage-
ment. Extant literature also indicates that the particular bene-
fits and value patients perceive concerning any given technol-
ogy for their care process, influence their cognitive engage-
ment (Agarwal et al., 2013; Bashshur et al., 2011; Coulter &
Ellins, 2007; Hibbard et al., 2007).
The healthcare sector describes cognitive engagement
mainly as a critical factor in obtaining adequate and custom-
ized disease management plans for patients (Linn et al., 2011).
The importance of involving patients in learning and utilizing
new technologies lies in fostering their self-management skills
(Faber et al., 2017). Therefore, cognitive engagement in the
context of responsible AI in healthcare is explained as a piv-
otal element in legitimizing the patient’s expression of phys-
ical and emotional needs, thus better orienting professional
interventions (Marano & Nicolantonio, 2015). Responsible
AI technologies offer valuable devices and platforms to facil-
itate patient activation and engagement in self-care and pre-
ventive behaviors (Gambhir et al., 2016). The perceptions of
reasonable AI encourage patients to engage with them active-
ly. For instance, promises to prevent the harmful effects, fair-
ness in dealing with patients and their data, and transparency
in the processes will increase patients’ cognitive engagement
with such technologies. Thus, cognitive engagement with re-
sponsible AI is oriented by a broader vision of healthcare that
goes beyond the organizational boundaries of healthcare set-
tings. Responsible AI technologies seek to learn more about
health concerns and collaborate with physicians in making
treatment decisions, and communicate and share information
with them (Kim, 2015; Wimmer et al., 2016).
Cognitive engagement with responsible AI technology has
several positive consequences, one of which is perceived val-
ue (Chen et al., 2017). Numerous researchers have established
significant relationships between cognitive engagement and
perceived value. For example, Brodie et al. (2011) argued that
cognitive engagement with particular circumstances and ser-
vice environment leads to higher perceived values. Some stud-
ies have found that cognitive engagement is linked to the
assurance of instrumental and experiential values and pleasure
and satisfaction (Amit & Zott, 2001). Researchers have also
commented on the propensity of cognitive engagement to
strengthen perceived value (Eggers & Kaplan, 2013). In addi-
tion, the customer’s evaluation of the consumption experience
is fundamental in creating instrumental and terminal values
(Zeithmal, 1988). In healthcare, patients perceive several ben-
efits by the consumption of various service products that are
adjacent to their social and self-perception, which in turn af-
fects their ‘value-in-use’ (Gronroos & Gummerus, 2014). It
has also been established that firms essentially need to focus
on customer engagement, to add an array of values to the
service products. Recent studies offer cognitive engagement
with service products as a unit of analysis for value creation
(Chen et al., 2017). Patient benefits derived from cognitive
engagement with responsible AI technologies and artifacts
are essential for perceived values. Cognitive engagement with
responsible AI technologies forms the preferences for the pro-
cess of care and channelizes the instrumental and terminal
values by the rendered services. In this context, it appears that
cognitive engagement by patients with responsible AI tech-
nologies corresponds to their perceived instrumental and ter-
minal value (see Fig. 2).
Hence, we postulate that:
H5: Cognitive engagement with responsible AI medi-
ates the relationships between Responsible AI –
Instrumental Value and Responsible AI – Terminal
Value.
3 Methodology
To develop more robust inferences, extant literature in the IS
discipline calls for a mixed-method study (Venkatesh et al.,
2013), which adopts a sequential mixed method approach and
collects samples from both ends. Given the complex nature of
healthcare deliveries, this study argues that a mixed-method
approach offers the potential to enhance understanding of the
phenomena under study. Thus, the study’s objective of illus-
trating the dynamics of responsible AI is aligned with the
application of mixed methods. As indicated in Fig. 3, this
study employs a three-stage sequential design (Fox &
James, 2020), with data from each stage informing the next
stage (Creswell, 2006).
3.1 Qualitative Study
In the first stage (Study 1), an exploratory qualitative study
was conducted with in-depth interviews. A purposive sam-
pling strategy was utilized to recruit the participants. The sam-
pling criteria ensured the likelihood of healthcare profes-
sionals (senior medical officers, senior nursing staff, and tech-
nical officers) expressing their understanding of the
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constituents of responsible AI in healthcare. The criteria for
the interviewees were experience in and knowledge of respon-
sible AI. The exploratory interviews emphasized the partici-
pants’ perception of responsible AI and their views as to the
constituents and consequences of responsible AI. The inter-
view guide was prepared from the concepts derived from the
extant literature. We utilized a few open-ended questions
(Appendix Table 9) to explore the concepts under study and
identify the additional items to establish responsible AI con-
structs. A total of 26 interviews were conducted in multiple
rounds (Appendix Table 10). Typically, interviews were con-
ducted in the respective offices of the respondents and lasted
between 40 and 60 min.
We analyzed the transcriptions utilizing framework
analysis (Harrison & Reilly, 2011). The exploratory inter-
views confirmed the relevance of the concepts and con-
structs drawn from the literature. Respondents expressed
their perceptions of various facets of responsible AI
(Table 1). Two of them described the technical issues in-
volved with responsible AI, explaining how the data and
algorithm are sensitive issues for responsible AI. Research
has shown that technical skills related to data set acquisi-
tions and processing are crucial in the design of AI systems
(Leslie, 2019). Evidence suggests that choosing the right
data and the right algorithms delivers a fair outcome
(Amoore & Raley, 2017; Deven & Joshua, 2017).
Further, the algorithms should be robust and better in-
formed. Respondents substantiate the data- related factors
(Gupta & George, 2016) and emphasize the use of relevant
and quality data. Past studies have emphasized the impor-
tance of aligning with the stakeholder’s expectations for
the use of their data (Hota et al., 2015). Two respondents
expressed the patients’ concern of their data being
manipulated and of privacy invasion issues as service
ethics, remarking that they were trying to minimize
privacy invasion to build a level of trust. In the
exploratory interviews, respondents revealed potential
threats of ethical issues and their impact on a responsible
AI system. For instance, they expressed concern for the
safety of human lives in robotic surgery. Shaikhina and
Khovanova (2017) posited that AI could obtain personal
information that may give rise to ethical issues. The inter-
view analysis confirms various risk management strategies
as a vital factor of responsible AI. Three respondents
agreed that adaptive capacity and transparency are essen-
tial to design responsible AI systems and artifacts and that
Fig. 2 Proposed conceptual
model.(Source: author’s
conceptualization)
Fig. 3 Research design
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responsible AI developments can be visualized as a collec-
tive action problem with risk mitigation, requiring success-
ful coordination with different activities.
The interviews revealed four items of the various con-
structs utilized in the next stage measurement scale, the quan-
titative study. Consequently, we added four measurement
items- (DD2, Alg1, SRE1, Cop2) in our model to conduct
the survey (Appendix Table 11).
3.2 Stage II: Quantitative Assessment
A measurement scale was constructed for the quantitative
assessment of the proposed model. The measurement pa-
rameters were adopted from the extant literature, and four
items were the outcome of exploratory interviews
(Appendix Table 11). The scale items were adapted from
previous studies and modified to suit the context of the
study and ensure face validity. A pre-test of the survey






1 Data “Huge amount of patient data is generated at various levels. Healthcare systems
have started maintaining data infrastructure both through vendors and
in-premise. Utmost important is to be sensitive about patient data….The
continuous analysis in a systematic way as we express our responsiveness
toward the patient and community in general. We advise the vendors to maintain
relevant data. In fact, we have check-ins to ensure fairness. The skills for data
handling should ensure a great focus on accuracy”.
Medical Director, 61, Male
2 Algorithm “For example… If a particular application is used for predictions of skin disease or
cancer, the patients are only concerned about the recommendation of the model
or about the prognosis. The technical skills of the developers must ensure the
prevention of malfunctions. The expertise must not only be in performance …
the computer programs and algorithms…. rather they should be sensitive to
human lives and values”.
Medical IT Officer, 49, Male
3 Individual Ethics “The most significant factor in the current AI based systems is how a professional
regards to moral values. The security and privacy of patient data are highly
dependent upon the medical professional’s individual ethics. As we join this
profession, we take oaths… I will keep it secret, I will consider all things to be
private. I would say…While utilizing AI…This oath should be kept in mind”.舃
Medical Dean, 58, Female
4 Service Ethics “The medical service has its own considerations regarding the patient-related data
or its harmful effect. We have an ethics committee to ensure the fair execution of
services and medical records. We should attempt that AI can be an ethical
producer and satisfy the patient”.舃Chief Operating Officer, 52, Male
5 Adaptability “The AI solutions must not be a rigid system. It must consider the changes from
time to time as per the emergent needs. We often discuss with the medical IT
department and our technical service providers regarding the problems or the
other effects. The solution must incorporate the changes and should be quickly
reconfigured, particularly when some harmful effects are reported.“
Medical Director, 61, Male
6 Cooperation “Such advanced technology is a group effort. Of course, we are at a nascent stage.
We don’t claim to be technology experts; however, many of us are now skilled.
Our technology vendors, the government departments, the medical council, the
other technical societies- all work together so that the various risks of AI can be
fully understood, protected by laws, and collaborative efforts can be made to
reduce the risks”.
Medical Dean, 58, Female.
7 Transparency “While utilizing AI technologies in medical care, it must explain the mechanisms
and assumptions… all the implementations should be done in a way that is
known to the patients or users. All involved parties should be taken obligations
to provide safety to all the human beingwho is associatedwith the AI, directly or
indirectly- in a way, and the understandable explanations should be there”.
Medical IT Officer, 49, Male
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instrument was administered to seven academicians and
six healthcare professionals, to establish the question-
naire’s content validity. We also followed the recommen-
dations of Malhotra et al. (2006) while designing the
questionnaire, to reduce the effects of common method
bias (CMB). We provided brief descriptions of the scale
items and also ensured the anonymity of the respondents.
The final scale (five-point Likert-scale with 1 = strongly
disagree to 5 = strongly agree) for the survey (Study I)
consisted of seven constructs and 26 items.
We conducted a survey of healthcare professionals in India,
consisting of all the first-order constructs of responsible AI
(seven constructs). The sampling frame was the top five
performing hospitals in India. The inclusion criteria were
bed strength, the volume of patients, and healthcare firms’
market performance. We approached the potential respon-
dents (Table 2) through email and requested them to partici-
pate in the survey. A total of 290 valid responses were collect-
ed (55.17% male, with more than 77% between 28 and 48
years). The survey participants first responded to items about
their experience with AI-enabled tools and platforms. A fur-
ther explanation on scales was provided to ensure clarity and
accuracy.
3.2.1 Hierarchical Model Specification
We first specified the hierarchical model, which represents the
relationships between the higher-order constructs, sub-
dimensions, and the measurement indicators. We constructed
the model indicating the first and second-order constructs as
reflective (Mode A), based on the related studies and subse-
quent conceptualization. The third order was constructed as
formative (Mode B). To depict the hierarchical model in PLS-
SEM, we first constructed the first-order latent variables and
connected them to their corresponding indicators (cf. Gupta &
George, 2016).The repeated item indicator approach recom-
mended by Hair et al. (2016) was utilized to form the second-
order latent constructs. The third-order factor (RespAI) was
constructed by repeating the indicators of all the first-order
factors (Fig. 4).
The partial least squares (PLS) approach to SEM (PLS-
SEM) is used for the estimation of a complex and hierarchical
model with the assumptions of soft modeling (Vinzi et al.,
2010). We applied PLS path modeling to avoid the limitations
of sample size and distributional properties (Sharma, 2019).
Smart PLS3 software was used to conduct a non-parametric
bootstrapping procedure with 5,000 re-samples and estimate
the model (Ringle et al., 2017). We followed higher-order
modeling procedures to establish the third-order construct
(Resp AI) and developed its valid measurement instrument
(Hair et al., 2016; Tenehaus et al., 2005).
3.2.2 Results
The measurement or outer model validation is the first step in
PLS-SEM analysis (Sharma et al., 2017). The measurement
model’s assessment consists of indicator reliability, internal
consistency (composite reliability), convergent validity, and
discriminant validity. Outer loadings of all the first-order re-
flective constructs were statistically significant. Cronbach’s
(1951) alpha and the composite reliability values (CR) were
above the recommended values of 0.7 (Table 3). The con-
struct’s convergent validity was established, as the average
variance extracted (AVE) values were above the recommend-
ed value of 0.5 (Hair et al., 2016). We dropped three items of
the scale (DD4, INE1, and COP3) due to inadequate loadings.
The discriminant validity of first-order constructs was also
established as follows (Table 4). First, AVE’s square root
was greater than its highest correlation with any other con-
struct (Fornell & Larcker, 1981). Second, each construct’s
outer loadings were greater than its cross-loadings with other
constructs (Hair et al., 2016).
The structural model was estimated using the bootstrapping
procedure with 5000 resamples (Hair et al., 2016). The boot-
strap test indicated that the loadings were highly significant.
The multicollinearity for each construct’s predictors was
checked using VIF values (Table 3), which were lower than
5 as recommended by Hair et al. (2016).
Table 2 Sample characteristics







Para-medical staff 16 19.31
Medical IT staff 52 04.13
Others 27 09.31
Education




<5 yrs. 40 13.79
5 To 10 yrs. 65 22.41
10 To 15 yrs. 78 26.89
15 To 20 yrs. 22 07.58
>20 yrs. 85 29.31
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We evaluated the hierarchical model next. The study first
intended to establish the three second-order factors –
Technical Skills, Ethical Concerns, and Risk mitigation. The
indicator weights of the second-order constructs – (1) Data
(β = 0.491, t = 12.331, p = 0.000) and Algorithm (β = 0.735,
t = 17.069, p = 0.000) on ‘Technical Skill’ (2) Individual
ethics (β = 0.470, t = 21.441, p = 0.000) and Service-ethics
(β = 0.654, t = 28.041, p = 0.000) on ‘Ethical concerns’ and
(3) Adaptability (β = 0.428, t = 21.065, p = 0.000), Co-
operat ion (β = 0.331, t = 18.472, p = 0.000) , and
Transparency (β = 0.456, t = 23.63, p = 0.000), on ‘Risk mit-
igation’ factors- were significant. Further, the indicator
weights of the third-order construct – Technical Skill (β =
0.467, t = 35.517, p = 0.000), Ethical Concerns (β = 0.436,
t = 31.020, p = 0.000) and Risk mitigation (β = 0.455, t =
36.483, p = 0.000) were statistically significant (Fig. 5). We
assessed the structural model by path co-efficient, t-statistics,
and p-values (Table 5). Further, blindfolding procedures were
utilized to obtain predictive relevance (omission distance = 7).
Results demonstrated positive Q2 (construct cross-validated
redundancy) values for Technical Skill (Q2 = 0.3299),
Ethical Concerns (Q2 = 0.409), Risk Mitigation (Q2 = 0.375),
and Resp AI (0.204), thus indicating a satisfactory predictive
relevance. Finally, the overall model fit was assessed by using
standardized root mean square (SRMR) residuals as an index
for model validation (Henseler et al., 2014). The PLS results
indicated an SRMR value of 0.058, which is less than the
threshold of 0.10 (Hair et al., 2016).
3.3 Study III: Quantitative with Dyadic Sample
After establishing the Resp AI construct as a third-order for-
mative factor, the next stage of the study intended to assess the
strength of the proposed relationships. Data for study III were
collected from those in charge of various medical units and
patients. A separate survey was created by adding questions of
market performance construct and the refined set of items for
Resp AI. We checked whether any respondent from the initial
survey was also involved in this data collection stage. Further,
these respondents were requested to provide the name and
contact details of at least two or three patients. These partici-
pants (patients) had been using AI-enabled tools or other plat-
forms for the last one to two years (e.g., - ‘FitBit’, wearable
ECG, chat boats). Thus, we further found the respondents’ list,
which consisted of the other end of the healthcare provider-
patient dyad (Gooty & Francis, 2011). The patients’
Fig. 4 Hierarchical model specification - responsible AI
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questionnaire consisted of three constructs with four measure-
ment items: cognitive engagement, instrumental value, and
terminal value. Snowball sampling was utilized to reach the
other end of the healthcare provider-patient dyad
(Gummenson, 2005). Thus, a sample of 174 dyads was
formed.
We further utilized PLS-SEM to assess the strength of the
relationships depicted in the hypothesized model (Fig. 2). A
similar method was followed to evaluate the outer loadings of
the first order constructs, which were found to be significant
(> 0.7), and construct reliability was also established
(Table 6). For reflective constructs, the AVE values were
greater than 0.5. The discriminant validity results are given
in Table 7.
The structural model was estimated through bootstrapping.
The direct impact of Resp AI on INV (β = 0.531, t = 14.665,
p = 0.000) and TNV (β = 0.465, t = 12.257, p = 0.000) was
significant. Thus, the hypothesis H1 and H2 are supported
(Table 8).Mediation analysis was performed as recommended
by Baron and Kenny (1986). The strength of this relationship
was suppressed (Table 3) when the mediating variable (Cog
Eng) was introduced. However, the impact of Resp AI on Cog
Eng (β = 0.561, t = 15.427, p = 0.000) and the relationships of
Cog Eng-INV (β = 0.245, t = 3.708, p = 0.001) and Cog Eng-
TNV (β = 0.220, t = 3.413, p = 0.001) were significant.
Moreover, the indirect relationships Resp AI-INV (β =
0.205, t = 3.075, p = 0.002) and Resp AI-TNV (β = 0.205,
t = 3.075, p = 0.002) were also significant. Thus, the media-
tion mechanism (H3) of Cog Eng was established. Finally, the
impact of INV on MKP (β = 0.0.270, t = 2.071, p = 0.038)
was significant, while that of TNV on MKP (β = 0.151, t =
1.198, p = 0.231) was insignificant (Fig. 6). Thus, hypothesis
H4 was supported, while H5 was not supported.





DD1 0.754 22.87 1.358
DD2 0.739 22.918 1.264
DD3 0.672 13.546 1.214
DD5 0.672 10.912 1.242
Algorithm 0.824 0.545
ALG1 0.765 23.782 1.42
ALG2 0.756 26.929 1.384
ALG3 0.695 24.388 1.282
ALG4 0.72 26.322 1.362
Individual ethics 0.777 0.538
INE2 0.727 21.858 1.384
INE3 0.761 26.297 1.219
INE4 0.712 20.891 1.155
Organizational ethics 0.809 0.515
SRE1 0.747 25.204 1.333
SRE2 0.723 21.227 1.302
SRE3 0.682 15.78 1.229
SRE4 0.717 22.192 1.137
Adaptability 0.764 0.519
ADT1 0.707 17.766 1.161
ADT2 0.764 28.344 1.326
ADT3 0.687 19.736 1.096
Cooperation 0.807 0.676
COP1 0.802 30.494 1.143
COP2 0.842 46.349 1.244
Transparency .774 .533
TR1 0.702 21.111 1.529
TR2 0.729 21.07 1.190
TR3 0.7759 28.418 1.219
Table 4 Test for discriminant validity















Cooperation 0.415 0.502 0.822
Data 0.27 0.302 0.158 0.71
Ethical
Concerns
0.182 0.112 0.196 0.016 0.644
Individual
Ethics
0.179 0.084 0.177 0.002 0.844 0.733
Resp AI 0.71 0.761 0.63 0.448 0.577 0.49 NA
Risk
Mitigation
0.834 0.659 0.738 0.267 0.232 0.203 0.844 0.617
Service
Ethics
0.149 0.11 0.172 0.026 0.923 0.572 0.529 0.208 0.718
Technical
Skill
0.538 0.883 0.447 0.713 0.075 0.063 0.78 0.616 0.069 0.581
Transparency 0.590 0.565 0.505 0.214 0.195 0.149 0.727 0.875 0.19 0.521 0.73
*Diagonal elements are the square root of AVE.
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4 Discussion
In this study, we specifically examined the design and
implementation of responsible AI in the Indian healthcare
context. The mixed-method approach provided insight
into the critical constituents of responsible AI in
healthcare. The findings revealed three significant pillars
of responsible AI in the context of healthcare deliveries:
technical skills, ethical concerns, and risk mitigation.
Identification of the three facets of responsible AI further
Table 5 Path Co-efficient: Third
Order factor validations Direct Impact Path Coefficient T Statistics P Values
Adaptability -> Risk Mitigation 0.429 20.145 0.000
Algorithm -> Technical Skill 0.702 15.613 0.000
Cooperation -> Risk Mitigation 0.33 17.565 0.000
Data -> Technical Skill 0.527 12.454 0.000
Ethical Concerns -> Resp AI 0.455 30.28 0.000
Individual Ethics -> Ethical Concerns 0.486 20.366 0.000
Organizational ethics -> Ethical Concerns 0.634 25.199 0.000
Risk Mitigation -> Resp AI 0.442 30.685 0.000
Technical Skill -> Resp AI 0.463 31.486 0.000
Transparency -> Risk Mitigation 0.453 22.5 0.000
Fig. 5 Bootstrapping – responsible AI as a third-order factor
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divulged exciting aspects of their healthcare implementa-
tion. For instance, exploratory interviews revealed that
healthcare professionals are becoming competent and
skilled in areas other than medicine. This was highlighted
as an essential concern as continuous medical education
remains an essential priority for most healthcare profes-
sionals. The learning requirements associated with re-
sponsible AI create a divergent learning track that needs
balancing and integration.
Excessive focus on the collection of data was another pri-
mary concern emerging from the qualitative study.
Respondents indicated that their decisions are increasingly
based on recent data, and the department concerned is in-
volved in a continuous evaluation of a large variety of data.
The complexity of socially beneficial AI technology necessi-
tates a collaborative effort with technology vendors (Fox &
James, 2020). However, the level of trust in these vendors
regarding medical data (e.g., fertility, sexual health, fetal dis-
eases, etc.) is significantly low. Some of the interviewees
pointed out that while various oaths and medical ethics govern
the privacy concerns with respect to healthcare professionals,
there is no similar safeguard in respect of technology vendors.
The existence of a large number of small and new technology
firms as against big and established ones in the domain of
responsible AI might also have amplified such privacy
concerns.
Further, it emerged from the qualitative study that the al-
gorithmic issues prominent in various healthcare applications
are equally important and cannot be ignored. Hence, legisla-
tion must safeguard healthcare data and prevent privacy inva-
sion, to ease the leveraging of responsible AI in healthcare.
During the qualitative data collection, we also observed that if
healthcare professionals are sensitive to risk management ac-
tivities, their responsiveness towards AI technologies is
higher. The exploratory interviews with healthcare profes-
sionals helped in understanding the relevance of the constructs
under study, as well as identifying its measurement
parameters.
The study further utilized a survey of healthcare profes-
sionals. The PLS-SEM analysis establishes responsible AI
as a third-order formative construct. As expected, we found
Table 6 Study III (Reliability and
validity indices) Outer Loadings t-value VIF CR AVE
Cognitive engagement 0.810 0.621
Cog1 0.704 17.096 1.414
Cog2 0.757 24.34 1.465
Cog3 0.696 17.919 1.239
Cog4 0.713 18.331 1.276
Instrumental value (INV) 0.824 0.632
INV1 0.706 16.859 1.329
INV2 0.730 18.207 1.439
INV3 0.728 20.215 1.303
INV4 0.773 26.121 1.471
Terminal value (TNV) 0.815 0.589
TNV1 0.678 14.256 1.256
TNV2 0.727 16.966 1.412
TNV3 0.726 19.568 1.277
TNV4 0.765 25.126 1.425
Market Performance 0.813 0.525
MKT1 0.662 15.445 1.327
MKT2 0.810 30.678 1.367
MKT3 0.717 16.867 1.363
MKT4 0.695 15.146 1.229
Table 7 Tests for discriminant validity
Cog Eng INV MKP Resp AI TNV
Cog Eng 0.718
INV 0.456 0.735
MKP 0.423 0.404 0.723
Resp AI 0.561 0.514 0.463 NA**
TNV 0.401 0.883 0.39 0.446 0.725
*Diagonal elements are the square root of AVE
**Resp AI is a formative construct
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significant relationships between responsible AI and its
underlying dimensions such as technical skills, ethical con-
cerns, and risk mitigation. The specific dimensions of re-
sponsible AI bridge the gap between theory and practice by
providing insights into socially responsible AI’s design
mechanisms. The quantitative data further validated the
findings of the qualitative interviews. The empirically val-
idated factors of responsible AI have opened a new digital
healthcare arena that can meet the changing laws and reg-
ulations on privacy invasion. Such understanding of the
components of responsible AI pushes back the existing
theoretical knowledge on this domain and provides direc-
tion to tackle data security threats. The findings fill the
knowledge gaps in this area and offer structured mecha-
nisms to design and implement the responsible AI that
meets the stakeholders’ expectations. The study also
established these dimensions as second-order reflective
constructs. This is the first step to clarify the issues on
the formation of responsible AI (Wang et al., 2020). The
findings bridge the knowledge gaps in this area and pro-
vide a s t ructured mechanism for des igning and
implementing responsible AI that meets the expectations
of the stakeholders. The empirical study could validate the
hierarchical model as a reflective–formative model, and the
analysis of the structural model confirmed that the paths
are significant. In this way, the findings clarified the con-
cepts of reasonable AI, and a valid measurement instru-
ment was developed. As expected and aligned with the
exploratory interviews, the quantitative results indicate
that risk mitigation is the most crucial factor for developing
Table 8 Hypothesis testing








Resp AI -> INV (H1) * 0.377 0.064 5.866 0.000 Supported
Resp AI -> TNV (H2)* 0.323 0.061 5.280 0.000 Supported
INV -> MKP (H3) 0.151 0.126 1.198 0.231 Supported
TNV -> MKP (H4) 0.27 0.131 2.071 0.038 Not-Supported
Resp AI -> Cog
Eng(H5a)
0.587 0.033 17.761 0.000 Supported
Cog Eng -> INV (H5b) 0.245 0.066 3.708 0.000 Supported
Cog Eng -> TNV (H5c) 0.205 0.064 3.413 0.001 Supported
*When mediating variable is introduced, Resp AI -> INV and Resp AI -> INV direct effects are suppressed
Fig. 6 Bootstrapping – validated
conceptual model. *path coeffi-
cient and p-values
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responsible AI (Ismagilova et al., 2020). One implication
of this finding is that despite the skills and competency of
healthcare professionals in utilizing health information
systems, technology vendors’ design and execution in-
volve a risk. Therefore, it is necessary to consider the risk
mitigation activities as an effort in developing responsible
AI. Collaborative efforts with NGOs, technical societies,
and vendors will ensure a positive social and health impact.
We proposed an integrative framework of responsible
AI, cognitive engagement with AI-enabled technologies,
instrumental value and terminal value, and market perfor-
mance. The PLS-SEM analysis results reveal that respon-
sible AI significantly impacts the instrumental value and
terminal value (Amit & Zott, 2001). Further, the findings
indicate that the intensity of impact on terminal value is
more than on instrumental value. Numerous scholars have
shown interest in a firm’s value formation activities (Chen
et al., 2017; Rokeach, 1973). The study’s findings clarify
that responsible AI in healthcare is perceived as satisfac-
tory and good for healthier lives. Besides, responsible AI
improves the service quality and delivery mechanisms in
healthcare, affecting instrumental value (Zeithmal, 1988).
The quantitative assessment also confirmed the partial
mediation of cognitive engagement between responsible
AI-terminal value and responsible AI-instrumental value.
Therefore, patients place significant trust (Fox & James,
2020; Hung et al., 2007)in AI systems that are socially
beneficial, provide assurance of data security, and adapt
to their fast-changing healthcare needs. The responsive-
ness of AI-enabled technologies (e.g., assurance of data
security, quick recovery of malfunctions and collaborative
initiatives for overall health benefits) facilitate patient ac-
tivation and engagement in self-care and preventive be-
haviors. Finally, we found that the instrumental value af-
fects market performance, though the relationship be-
tween terminal value and market performance was not
significant. Our empirical analysis suggests that the in-
strumental value (increased knowledge about healthcare,
level of satisfaction with AI-based service provisions, and
the overall healthcare service quality) significantly affects
healthcare firms’ market performance (Ravichandran &
Lertwongsatien, 2005; Zeithmal, 1988). The findings sug-
gest that development of responsible AI allows healthcare
firms to increase market share and introduce new and
innovative services.
4.1 Theoretical Implications
Based on our research findings, there are several implica-
tions for theory. First, our study responds to the recent
calls by existing studies (Barello et al., 2016; Reddy,
2018; Shukla & Sushil, 2020; Wang et al., 2020) to iden-
tify the constituents of responsible AI. The current study
precisely explains how technical skills, ethical concerns,
and risk mitigation factors affect responsible AI in the
healthcare context. Though much effort has gone into ex-
ploring the technological understanding of AI implemen-
tation, studies seeking to leverage the ecosystem of re-
sponsible AI are scarce. Despite the emerging importance
of micro-foundations of psychological underpinnings
(Huang & Chang, 2012; Swar et al., 2017), very little is
known about the patient’s cognitive engagement with AI
and its impact on value formation and market perfor-
mance. This study fills this knowledge gap.
Second, several versions of the constructs of AI and its
antecedents have been utilized in the literature (Duan et al.,
2019; Grover et al., 2020; Wang et al., 2018). Many studies
across various contexts have outlined different independent
variables that could influence responsible AI (Shareef et al.,
2021; Wearn et al., 2019). To the contrary, only a few papers
are found on what and how responsible AI might influence.
Although these noble pursuits invite attention, we examined a
wealth of literature relating to responsible AI. This study is the
first step to establishing responsible AI as a multi-dimensional
third-order construct and investigating a mixed-method
approach.
Third, recent researchers have explored the managerial
cognitive perspectives of customer benefit and value cre-
ation, by considering previous foundations of means-end
theory and service-dominant logic (Chen et al., 2017;
Skålén et al., 2015). Our empirical studies extend these
frameworks by integrating customers’ psychological per-
spectives and contribute to marketing literature by
explaining the dynamics of customer interactions with
AI-enabled technologies and service products.
Fourth, the current study’s findings conjoin the IS and
marketing li terature by investigating the under-
represented fields of data privacy, ethical concerns, and
co-operative developments and their impacts on market
performance. This study also goes beyond the customer-
dominant logics of value formation (Brodie et al., 2011;
Heinonen et al., 2013), by revealing how responsible AI
contributes to their perceived value. Further, our study
pushes back the existing frontiers of knowledge
concerning technology adoption (Rahman et al., 2016)
by the customers and argues that responsible AI systems
and artifacts facilitate their cognitive engagement, which
is essential from marketing perspectives.
Finally, the findings of our study are also consistent
with some previous studies that accept the role of cogni-
tive engagement with different facets of service deliveries
and its positive outcomes (Barello et al., 2014; 2016;
Graffigana et al., 2015). Our study further explains that
cognitive engagement with AI-enabled technologies in
healthcare by patients has several benefits, affecting value
creation. The study also supports prior studies on data
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security, privacy invasion, and ethical concerns in
healthcare. Of particular note is the study’s finding re-
garding pr ivacy invasion, quick recovery from
malfunctions, and cooperation with technology vendors.
The implicit discussions regarding these elements exist
in the literature. Only our mixed-method study included
these parameters into a comprehensive model and clari-
fied how they are important in implementing responsible
AI in healthcare.
4.2 Practical Implications
AI technologies could enable access to a full continuum of
care and create an ecosystem with in-home monitoring, acute
functionality, and patient assistance for high-value therapies.
However, these rapid developments also require technical
skills to handle data and algorithms safely, raise individual
and service ethics and emphasize riskmanagement. This study
highlights the apparent areas of understanding of how respon-
sible AI may be shaped in the healthcare context. The techni-
cal challenges relating to data-set appropriateness and suitabil-
ity and the explainability of algorithms require expertise and
team effort. The results suggest that algorithmic issues need
much attention to become executable at the frontline of med-
ical care. The study also suggests legitimate data security and
privacy invasion avoidance, which are prima facie lacking in
current Indian healthcare systems. Integration of healthcare
provisions with AI technologies throws up an urgent need
for healthcare providers and technology vendors to work col-
laboratively for the best socio-economic outcomes. The
study’s findings outline the implementation of responsible
AI in healthcare by placing the humans (patients and
healthcare professionals) at the center and assess how
healthcare companies can be benefitted by the potential
healthcare market, as envisaged by the Indian Brand Equity
Foundation.
The study’s findings are also aligned with the need for
innovations in data science and artificial intelligence, to
support global efforts to combat outbreaks of a pandemic
like COVID-19 (Al-quaness et al., 2020; Wang et al.,
2018). Implementing AI solutions that are socially re-
sponsible would enable medical scientists and technolo-
gists to address a wide range of biomedical and epidemi-
ological challenges. This study depicts specific steps to
tackle COVID-19 challenges by utilizing responsible AI,
such as generating public trust through transparency, re-
specting individual dignity, and facilitating evidence-
based clinical decisions (Khalifa et al., 2019; WHO,
2020a). We further argue that understanding cognitive
engagement perspectives will provide insights to auto-
mate, target, and personalize healthcare marketing activi-
ties. For example, the perceived value of wearable devices
and other AI-based health monitoring tools will lead to
market growth. The fair and safe use of AI tools will
increase the patient’s engagement in influencing
healthcare firms’ market performance. Our study’s find-
ings shed light on the unexplored ramification of psycho-
logical mechanisms of cognitive engagement and provide
direction to managers for developing value propositions
(e.g., increasing awareness programs, providing assurance
of safety, and communicating the convenient use of such
AI-based tools).
Further, the study complements and extends the service
product perspective by linking the responsible production
mechanisms of AI with the patients’ perceived terminal
and instrumental value. The rigorous model depicted in
this study allows firms to develop appropriate combina-
tions of patient benefits for their AI-enabled tools and
platforms. In this way, healthcare firms become patient-
centric (Barello et al., 2016), by focusing on marketing
capabilities driven by such socially responsible AI
technologies.
The study findings suggest that healthcare firms should
design service products in general and AI-enabled tools,
particularly by taking into account both medical modern-
ization and ethical concerns. The current findings also
provide guidelines for healthcare practitioners and
policymakers to implement responsible AI for better clin-
ical outcomes, as well as patient benefits such as standard
operating procedures for AI tools, regulation for data pri-
vacy protection, training to improve technical skills, re-
ducing harmfulness, quick actions for recovery, and
conducting audits of the transparency. Our study results
suggest that healthcare policymakers should adopt a
broader perspective of strategic choices and abandon the
rigid delivery models. Moreover, the findings suggest
how healthcare managers can focus on developing dy-
namic cognitive capabilities (Almquist et al., 2016) to
identify responsible AI’s perceived benefit and its linkage
with value formation. Further, the model proposed in this
study may also facilitate scrutiny of healthcare practices
and offer value propositions through a wide array of AI-
enabled technologies that are socially responsible. From
the patients’ perspective, cognitive engagement with AI-
enabled technologies will facilitate positive perceptions
and create a level of trust while interacting with them.
4.3 Social Implications
The digital divide concerns and its possible negative so-
cial implication on society’s vulnerable sections have
always remained a critical apprehension for researchers.
Efforts to solve this challenge in the context of an
emerging technology must be made since the initial days
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of its conceptualization. Responsible AI is, in fact, an
attempt to solve this social challenge of equitable distri-
bution of benefits. By identifying dimensions of respon-
sible AI, this study would help the citizens group in two
key ways. First, by identifying the list of possible vul-
nerabilities like discrimination, autonomy, and privacy
invasion, this study would help them understand the pos-
sibility of unequal distribution of benefits from AI appli-
cation in the domain of healthcare. Second, by identify-
ing risk mitigating strategies like adaptability, coopera-
tion, and transparency, this study would further help the
citizens group in directing their resources towards
established and scientifically proven managerial solu-
tions. Active citizen groups working towards the cause
of equitable access to healthcare facilities would further
benefit by learning various aspects of applying responsi-
ble AI in healthcare.
Similarly, the managers and owners of healthcare firms
would benefit from a better understanding of responsible
AI. They would be able to serve the diverse population
with effective and efficient healthcare offerings. This
study would also equip them with knowledge of balancing
growth and sustainability, thus providing long-term bene-
fits to society. The study would further guide the younger
generation in identifying the requirement of skills in these
emerging domains – the scope for which is expected to
follow a sharp upward trajectory. It will thus help them in
preparing themselves for the future job market. The find-
ings suggest how the responsible AI solutions can lower
the barriers between hospitals and patients and improve
access to care, particularly in tier II and tier III cities of
India. The findings also provide ways to develop a vibrant
start-up ecosystem that goes beyond the clinical services
to a new business model of wellness, prevention, moni-
toring services, even in non-metro cities of India.
4.4 Limitations and Future Research Avenues
The present study, though it has certain limitations, gen-
erates some avenues for future research. First, the study
was conducted in an Indian context. Future research
should test the framework’s generalizability in contrast-
ing contexts (emerging country healthcare) to provide a
robust understanding. A fruitful avenue of future re-
search is the extension of the framework by considering
the cultural characteristics and collecting the multi-
national samples to assess the strength of the relation-
ships. Second, the study contributes to the constituents
of ‘Responsible AI’ in healthcare by considering several
psychological and social aspects. However, there may be
other contextual variables affecting the formation of
Responsible AI, which remain unexplored. Future
studies should also be conducted to better understand
the antecedents of responsible AI. Third, we believe that
the nature of tasks and the degree of involvement with
AI-enabled technology may also moderate this relation-
ship. For example, different users may use different tools
and platforms as per their requirements. Task-related and
rational motives may affect the perceived benefits and
value differently. Future researchers should take into ac-
count the moderating roles of such variables and explore
these issues of personal habits and task characteristics,
which the current study has not considered. Finally, the-
ories of psychology suggest that the factors responsible
for cognitive engagement are affected by the brands of
service products, and may also change over time.
Therefore, a longitudinal study considering the brand
values of the AI-enabled technologies will provide more
useful insights to strengthen the theorizing in this
context.
5 Conclusions
The widespread interest in responsible AI shown by
scholars and practitioners motivated this research article.
Although several industry reports and contributions of
practitioners have populated the literature on responsible
AI, researchers have only recently begun exploring its
underlying dynamics. In essence, this study provides a
background to the infrastructure and ecosystem that sup-
ports the formation of responsible AI in the healthcare
context. This study highlights the dark side that a typical
AI project could present and thus addresses an urgent
need to develop AI technologies with social and ethical
concerns. In doing so, we adopted a mixed methodology,
using a sample of both healthcare professionals and cus-
tomers (patients) in India. Our results first identify the
constituents of responsible AI and establish it as a third-
order factor with three underlying dimensions: technical
skills, ethical concerns, and risk-mitigation. We found
that data and algorithmic issues, privacy invasion, adapt-
ability, quick recovery from malfunctions, and collabora-
tive efforts were important in shaping responsible AI in
healthcare. The insights of the study can be used for eas-
ing the leveraging of responsible AI in India. Our findings
guide healthcare firms in designing and implementing re-
sponsible AI, while simultaneously clarifying how such
technological advancements affect patients’ cognitive en-
gagement. Our findings provide the insight that responsi-
ble AI affects the value formation and market perfor-
mance of a healthcare firm.
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Appendix
Table 10 Respondent’s profile in
qualitative study Sl. No. Role and profile Number of interviews Approximate duration
1 Medical Director, 61, Male 4 160 min
2 Medical IT Officer, 49, Male 4 180 min
3 Medical Dean, 58, Female 4 180 min
4 Chief Operating Officer, 52, Male 4 160 min
5 Senior Consultant, 47, Male 1 60 min
6 Senior Consultant, 43, Female 1 50 min
7 Senior Consultant, 59, Male 1 50 min
8 Senior Consultant, 51, Female 1 50 min
9 Consultant, 40, Male 1 60 min
10 Consultant, 41, Female 1 60 min
11 Chief Administrative officer, 44, Male 2 100 min
12 Medical Record Officer, 37, Male 2 120 min
Table 9 Interview agenda
Sl. No. Interview agenda
1 Prevalence of AI based applications in hospital
2 History of implementation of AI based solutions
3 Process of skill development for healthcare professionals
4 Various challenges of implementation
5 Ethical concerns (possibility and past complaints)
6 Types of ethics and ways to handle them
7 Trust between various stakeholders
8 Privacy concerns
9 Evidence-based medicine and AI
10 Reducing malfunctions
11 Role of the technology partner and relationships with them
12 Risk associated with AI and how does it differ from other technologies
13 Cost and benefits from AI
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Table 11 Measurement scale
Measurement items Reference
Data (Gupta & George, 2016)
We integrate data for high-value analysis for our business environment (DD1)
We continuously assess our data for responsible execution (DD2)**
Our decisions are based on data rather than our instinct (DD3)
We include fairness in data selection (DD4)
We use the data set that are relevant to the population (DD5)
Algorithm (Al-quaness et al., 2020)
We ensure that the design of our algorithms should be explainable (Alg1)**
We continuously attempt to reduce algorithm biases (Alg2)
We have a monitoring system for the development of AI systems (Alg3)
We are sensitive to make the algorithms robust (Alg4)
Individual Ethics
We are impartial and avoid unfair discrimination (INE1)
We avoid violation of trust (INE2)
We deal fairly with people (INE3)
We respect each person’s autonomy (INE4)
Service-ethics
We maintain privacy invasion (SRE1) **
We conceive the AI only after ensuring sufficient understanding of purposes (SRE2)
We ensure that the responsible entity is apparent (SRE3)
We conduct an impact assessment to ensure less harmful ways of achieving the objective (SRE4)
Adaptability (Fox & James, 2020)
We ensure the adaptive performance of intended functions (ADT1)
We quickly reconfigure our programs as per the requirements(ADT2)
We resist processing when unexpected harm arises (ADT3)
We recover when malfunctions occur (ADT4)
Co-operation (Fox & James, 2020)
We advocate a more thorough mapping of possible collaboration (Cop1)
We associate with our partners to work in a collaborative environment (Cop2)**
We take collective action on responsible AI development (Cop3)
Transparency (Fox & James, 2020)
AI-based processes are transparent to all stakeholders (TRP1)
We ensure that the people are aware of actions and inferences (TRP2)
All entities have obligations to procedural fairness (TRP3)
Market Performance (MP) (Ravichandran & Lertwongsatien, 2005)
We have entered a new market quickly (MKP1)
We have added news services for the patients quickly (MKP2)
Our success rate is higher as compared to our competitors (MKP3)
Our market share has increased (MKP4)
Cognitive Engagement (Cog Eng) (Graffigana et al., 2015)
I feel comfortable in utilizing AI technologies (Cog1)
I understand that AI-enabled platforms are essential for health- development (Cog2)
I believe that AI enabled tools are not risky (Cog3)
The features offered by AI-enabled tools can be adjusted to fit our need (Cog4)
Instrumental value (INV) (Chen et al., 2017)
The use of the AI-enabled platform can increase our abilities (INV1)
The use of the AI-enabled platform can increase our imagination (INV2)
The use of the AI-enabled platform can inspire our curiosity (INV3)
The use of the AI-enabled platform can increase our knowledge (INV4)
Terminal value (TNV) (Chen et al., 2017)
The use of the online streaming platform helps you feel relaxed and happy (TNV1)
The use of the online streaming platform enhances your confidence (TNV2)
Family feelings become better after using the online streaming platform (YNV3)
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